<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Only rare cases of anti-Vel–associated mild-to-moderate hemolytic disease of the fetus and newborn have been previously reported. No case of fetal anemia requiring prenatal therapy has been noted to date. We report such a case recently encountered at our Fetal Center. Strategies are discussed for managing pregnancy complicated with alloimmunization to an antibody to a high-prevalence antigen, including sources of red blood cells for intrauterine transfusions. <italic><bold>Immunohematology</bold></italic><bold>2017;33:152–154.</bold></p></abstract>

Only rare cases of anti-Vel–associated mild-to-moderate hemolytic disease of the fetus and newborn have been previously reported. No case of fetal anemia requiring prenatal therapy has been noted to date. We report such a case recently encountered at our Fetal Center. Strategies are discussed for managing pregnancy complicated with alloimmunization to an antibody to a high-prevalence antigen, including sources of red blood cells for intrauterine transfusions. Immunohematology2017;33:152–154.

Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn

The Department of Pathology and Laboratory Medicine

Immunohematology

{"article-title":"Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn"}

Only rare cases of anti-Vel–associated mild-to-moderate hemolytic disease of the fetus and newborn have been previously reported. No case of fetal anemia...

Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn

Article Category: Original Report

Publicado en línea: 16 oct 2019

Páginas: 152 - 154

DOI: https://doi.org/10.21307/immunohematology-2019-021

Palabras clave
anti-Vel, Vel, red blood cell antibody, red blood cell alloimmunization, hemolytic disease of the fetus and newborn, intrauterine transfusion

© 2017 K.J. Moise et al., published by Sciendo

Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn

Article Category: Original Report

Publicado en línea: 16 oct 2019

Páginas: 152 - 154

DOI: https://doi.org/10.21307/immunohematology-2019-021

Palabras claveanti-Vel, Vel, red blood cell antibody, red blood cell alloimmunization, hemolytic disease of the fetus and newborn, intrauterine transfusion

© 2017 K.J. Moise et al., published by Sciendo

Palabras clave
anti-Vel, Vel, red blood cell antibody, red blood cell alloimmunization, hemolytic disease of the fetus and newborn, intrauterine transfusion